BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8096745)

  • 1. An update of Scandinavian studies of osteosarcoma.
    Elomaa I
    Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
    Graham-Pole J; Ayass M; Cassano W; Dickson N; Enneking W; Heare M; Heare T; Marcus R; Saleh R; Spanier S
    Cancer Treat Res; 1993; 62():339-46. PubMed ID: 8096749
    [No Abstract]   [Full Text] [Related]  

  • 3. The European Osteosarcoma Intergroup (E.O.I.) studies 1980-1991.
    Craft AW; Burgers JM
    Cancer Treat Res; 1993; 62():279-86. PubMed ID: 8096743
    [No Abstract]   [Full Text] [Related]  

  • 4. Update of osteosarcoma in Ramathibodi, Thailand.
    Sirikulchayanonta V; Pochanugool L; Subhadrabandhu T
    Cancer Treat Res; 1993; 62():371-4. PubMed ID: 8096752
    [No Abstract]   [Full Text] [Related]  

  • 5. The multi-institutional osteosarcoma study: an update.
    Link MP
    Cancer Treat Res; 1993; 62():261-7. PubMed ID: 7682087
    [No Abstract]   [Full Text] [Related]  

  • 6. Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.
    Miser JS; Pritchard DJ; Rock MG; Shives TC; Gilchrist GS; Smithson WA; Arndt CA; Edmonson JH; Schaid DJ
    Cancer Treat Res; 1993; 62():333-8. PubMed ID: 8096748
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.
    Kalifa C; Razafindrakoto H; Vassal G; Contesso G; Vanel D; Edeline V; Valteau D; Lemerle J
    Cancer Treat Res; 1993; 62():347-9. PubMed ID: 7682093
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
    Winkler K; Bielack SS; Delling G; Jürgens H; Kotz R; Salzer-Kuntschik M
    Cancer Treat Res; 1993; 62():269-77. PubMed ID: 7682088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
    Delepine N; Delepine G; Desbois JC
    Cancer Treat Res; 1993; 62():327-32. PubMed ID: 7682092
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of therapy in osteosarcoma: experience in childrens hospitals in Buenos Aires.
    Schvartzman E; Scopinaro M; Muriel FS
    Cancer Treat Res; 1993; 62():351-3. PubMed ID: 8096750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of osteosarcoma].
    Winkler K; Bieling P; Bielack S
    Z Orthop Ihre Grenzgeb; 1992; 130(4):285-9. PubMed ID: 1413973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.
    Berend KR; Pietrobon R; Moore JO; Dibernardo L; Harrelson JM; Scully SP
    J Surg Oncol; 2001 Nov; 78(3):162-70. PubMed ID: 11745799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
    Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
    J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
    Ekert H; Tiedemann K
    Cancer Treat Res; 1993; 62():355-9. PubMed ID: 7682094
    [No Abstract]   [Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.
    Bacci G; Picci P; Pignatti G; De Cristofaro R; Dallari D; Avella M; Manfrini M; Marangolo M; Ferruzzi A; Mercuri M
    Clin Orthop Relat Res; 1991 Sep; (270):87-98. PubMed ID: 1884564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
    Saeter G; Wiebe T; Wiklund T; Monge O; Wahlqvist Y; Engström K; Forestier E; Holmström T; Stenwig AE; Willén H; Brosjö O; Follerås G; Alvegård TA; Strander H
    Acta Orthop Scand Suppl; 1999 Jun; 285():74-82. PubMed ID: 10429627
    [No Abstract]   [Full Text] [Related]  

  • 17. An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma.
    Rosen G
    Cancer Treat Res; 1993; 62():49-54. PubMed ID: 8096759
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
    Bacci G; Picci P; Ferrari S; Avella M; Prever BA; Ruggieri P; Casadei R; Lari S; Monti C; Cazzola A
    Cancer Treat Res; 1993; 62():299-308. PubMed ID: 7682090
    [No Abstract]   [Full Text] [Related]  

  • 19. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results.
    Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A
    Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.